Therapeutic inertia in the outpatient management of dyslipidemia in patients with ischemic heart disease. The inertia study;Inercia terapéutica en el manejo extrahospitalario de la dislipemia en pacientes con cardiopatía isquémica. Estudio Inercia

Revista Espanola de Cardiologia

Volumn 63, Issue 12, 2010, Pages 1428-1437

  Lázaro, Pablo ^a   Murga, Nekane ^b   Aguilar, Dolores ^a   Hernández Presa, Miguel A ^c  

^a Tecnicas Avanzadas de Investigacion en Servicios de Salud TAISS   (Spain)

^b HOSPITAL DE BASURTO   (Spain)

^c PFIZER INC   (United States)

Author keywords

Ischemic heart disease; Lipid management; Therapeutic inertia

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; CLINICAL PRACTICE; CONSULTATION; CORONARY RISK; DYSLIPIDEMIA; HEALTH EDUCATION; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL RECORD; OBSERVATIONAL STUDY; OUTPATIENT; PHYSICIAN; QUESTIONNAIRE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AMBULATORY CARE; ATTITUDE OF HEALTH PERSONNEL; CHOLESTEROL, LDL; DYSLIPIDEMIAS; FEMALE; GUIDELINES AS TOPIC; HEALTH CARE SURVEYS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; QUESTIONNAIRES; REFERRAL AND CONSULTATION; RISK FACTORS; SPAIN; YOUNG ADULT;

EID: 78650693193     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/S0300-8932(10)70269-4     Document Type: Article

References (34)

1. L.S. Phillips, W.T. Branch, C.B. Cook, J.P. Doyle, I.M. El-Kebbi, and D.L. Gallina Clinical inertia Ann Intern Med 135 2001 825 834
2. S.E. Andrade, J.H. Gurwitz, T.S. Field, M. Séller, S.R. Majumdar, and G. Reed Hypertension management: the care gap between clinical guidelines and clinical practice Am J Manag Care 10 2004 481 486
3. E.C. Okonoufa, K.N. Simpson, A. Jesri, S.U. Rehman, V.L. Durkalski, and B.M. Egan Therapeutic inertia is an impediment to achieving th Healthy People 2010 blood pressure control goals Hypertension 47 2006 345 351
4. C. Salisbury, and T. Fahey Overcoming clinical inertia in the management of hypertension CMAJ 174 2006 1285 1286
5. D.C. Ziemer, C.D. Miller, M.K. Rhee, J.P. Doyle, Jr. Watkins C, and C.B. Cook Clinical inertia contributes to poor diabetes control in a primary care setting Diabetes Educ 31 2005 564 571
6. B.R. Shah, J.E. Hux, A. Laupacis, B. Zinman, and W.C. Van Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians? Diabetes Care 28 2005 600 606
7. J. Redón, A. Coca, P. Lázaro, M.D. Aguilar, M. Cabañas, and N. Gil Factors associated with therapeutic inertia in hypertension: validation of a predictive model J Hypertens 28 2010 1770 1777
8. R. Grant, A.S. Adams, C.M. Trinacty, F. Zhang, K. Kleinman, and S.B. Soumerai Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management Diabetes Care 30 2007 807 812
9. G. Mendelson, and W.S. Aronow Underutilization of measurement of serum low-density lipoprotein cholesterol levels and of lipidlowering therapy in older patients with manifest atherosclerotic disease J Am Geriatr Soc 46 1998 1128 1131
10. B.J. Turner, C.S. Hollenbeak, M. Weinwe, T. Ten Have, and S.K. Tang Effect of unrelated comorbid conditions on hypertension management Ann Intern Med 148 2008 578 586
11. E.A. Kerr, B.J. Zikmund-Fisher, M.L. Klamerus, U. Subramanian, M.M. Horgan, and T.P. Hofer The role of clinical uncertainty in treatment decisions for diabetic patients with uncontrolled blood pressure Ann Intern Med 148 2008 717 727
12. D. Fuke, J. Hunt, J. Siemienczuk, M. Estoup, M. Carroll, and N. Payne Cholesterol management of patients with diabetes in a primary care practice-based research network Am J Manag Care 10 2004 130 136
13. T.A. Pearson, I. Laurora, H. Chu, and S. Kafonck The Lipid Treatment Assesment Project (L-TAP). A multicenter survey to evaluate percentages of dyslipemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals Arch Intern Med 160 2000 459 467
14. J.H. Willig, D.A. Jackson, A.O. Westfall, J. Allison, Chang Pei-Wen, and J. Raper Clinical inertia in the management of lowdensity lipoprotein abnormalities in an HIV clinic HIV/AIDS CID 46 2008 1315 1318
15. A. Abuful, Y. Gidron, and Y. Henkin Physicians' attitudes toward preventive therapy for coronary artery disease: is there a gender bias? Clin Cardiol 28 2005 389 393
16. N. Rodondi, T. Peng, A.J. Karter, D.C. Bauer, E. Vittinghoff, and S. Tang Therapy modifications in response to poorly controlled hypertension, dyslipidemia and diabetes mellitus Ann Intern Med 144 2006 475 484
17. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
18. S.M. Grundy, J.I. Cleeman, C.N. Bairey, H.B. Brewer, L.T. Clark, and D.B. Hunninghake NCEP Report: implications of recent clinical trials for the National Cholesterol Education Program Adult Treatmen Panel III guidelines Circulation 110 2004 227 239
19. G.C. Fonarow, W.J. French, L.S. Parsons, H. Sun, and J.A. Malmgren Use of lipid-lowering medications at discharge in patients with acute myocardial infarction. Data from the National Registry of Myocardial Infarction 3 Circulation 103 2001 38 44
20. K.C. Goldberg, S.D. Melnyk, and D.L. Simel Overcoming inertia: improvement in achieving target low-density lipoprotein cholesterol Am J Manag Care 13 2007 530 534
21. P. Primatesta, and N.R. Poulter Lipid concentrations and the use of lipid lower ing drugs: evidence from a national cross sectional survey BMJ 321 2000 13225
22. A.A. Martínez-Hernández, M.J. Aguilar-Leñero, M. Rabadán Mengíbar, F. Hernansanz-Iglesias, J. González- Ramos, and A. Marín-Obáñez Prevención secundaria de cardiopatía isquémica a nivel lipídico en atención primaria Aragón. Estudio PRECIAR Rev Esp Salud Pública 75 2001 143 150
23. F.J. García Ruiz, A. Marín Ibáñez, F. Pérez-Jiménez, X. Pintó, G. Nocea, C. Ahumada REALITY Study Group Current lipid management and low cholesterol goal attainment in common daily practice in Spain. The REALITY Study Pharmacoeconomics 22 Suppl 3 2004 1 12
24. M.J. Medrano, R. Pastor-Barriuso, R. Boix, J.L. Del Barrio, J. Damián, and R. Álvarez Estudio ZACARIS. Riesgo coronario atribuible a los factores de riesgo cardiovascular en población española Rev Esp Cardiol 60 2007 1250 1256
25. J.R. González-Juanatey, E. Alegría-Ezquerra, J. Aznar-Costa, V. Bertomeu-Martínez, J. Franch-Nadal, and J.L. Palma-Gámiz Conocimiento y aplicación de las guías de práctica clínica sobre riesgo cardiovascular en las consultas generales y especializadas Rev Esp Cardiol 59 2006 801 806
26. B. Dahlöf, P.S. Sever, N.R. Poulter, H. Wedel, D.G. Beevers, and M. Caulfield Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomized controlled trial Lancet 366 2005 895 906
27. M.D. Aguilar, P. Lázaro, K. Fitch, and S. Luengo Gender differences in clinical status at time of coronary revascularization in Spain J Epidemiol Community Health 56 2002 555 559
28. M.D. Cabana, C.S. Rand, N.R. Powe, A.W. Wu, M.H. Wilson, and P.A. Abboud Why don't physicians follow clinical practice guidelines? A framework for improvement JAMA 282 1999 1458 1465
29. C.L. Roumie Improving blood pressure control through provider education, provider alerts, and patient education: a cluster randomized trial Ann Intern Med 145 2006 165 175
30. M.H. Davidson Strategies to improve adult treatment Panel III guideline adherence and patient compliance Am J Cardiol 89 Suppl 2002 C8 C22
31. N.M. Afonso, G. Nassif, A.N. Aranha, B. Delor, and L.J. Cardozo Low-density lipoprotein cholesterol goal attainment among high-risk patients: Does a combined intervention targeting patients and providers work? Am J Manag Care 12 2006 589 594
32. J.T. Van Wyk, M.A.M. Van Wikj, M.C.J.M. Sturkenboom, M. Mosseveld, P.W. Moorman, and J. Van der Lei Electronic alerts versus on-demand decision support to improve dyslipidemia treatment. A cluster randomized controlled trial Circulation 117 2008 371 378
33. Centro de Información y Evaluación de Medicamentos y Productos Sanitarios de la Región de Murcia. Hipolipemiantes Evaluación Farmacoterapéutica 1 2007 1 8
34. D.D. Waters, C. Brotons, C. Chiang, J. Ferrires, J. Foody, and W. Jukema Lipid Treatment Assesment Project 2. A multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals Circulation 120 2009 28 34